EV/EBITDA
-7.47
-0.33-4.62%
10 min ago
Summary
- As of March 12, 2025, RARE EV/EBITDA is -7.47, with a fall of -0.33 (-4.62%) during the most recent trading day.
- Over the past year, RARE EV/EBITDA has dropped by -0.32 (-4.48%).
- RARE EV/EBITDA is now -131.99% below its all-time high of -3.22.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -4.6% | +4.6% | +4.4% |
| 1 m1 month | +7.7% | -7.6% | -7.4% |
| 3 m3 months | - | - | -15.6% |
| 6 m6 months | +25.6% | -26.9% | -30.8% |
| ytdytd | - | - | -4.8% |
| 1 y1 year | -4.5% | -4.9% | -16.0% |
| 5 y5 years | -45.9% | +78.9% | -3.1% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.3% | -8.43 | +11.4% | |
| 3 m | 3-month | -7.03 | -6.3% | -8.49 | +12.0% |
| 6 m | 6-month | -7.03 | -6.3% | -11.36 | +34.2% |
| 1 y | 1-year | -5.97 | -25.1% | -11.36 | +34.2% |
| 3 y | 3-year | -3.22 | -132.0% | -13.68 | +45.4% |
| 5 y | 5-year | -3.22 | -132.0% | -75.56 | +90.1% |
| alltime | all time | -3.22 | -132.0% | -75.56 | +90.1% |
Ultragenyx Pharmaceutical EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.47(+51.8%) |
| 2022 | -4.92(-63.7%) |
| 2021 | -13.56(-77.9%) |
| 2020 | -61.40(+1054.1%) |
| 2019 | -5.32(-55.0%) |
| Date | Value |
|---|---|
| 2018 | -11.82(+89.7%) |
| 2017 | -6.23(-44.4%) |
| 2016 | -11.20(-61.6%) |
| 2015 | -29.16(+18.8%) |
| 2014 | -24.55 |
FAQ
- What is Ultragenyx Pharmaceutical EV/EBITDA?
- What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical EV/EBITDA year-on-year change?
What is Ultragenyx Pharmaceutical EV/EBITDA?
The current EV/EBITDA of RARE is -7.47
What is the all time high EV/EBITDA for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high EV/EBITDA is -3.22
What is Ultragenyx Pharmaceutical EV/EBITDA year-on-year change?
Over the past year, RARE EV/EBITDA has changed by -0.32 (-4.48%)